IRMD IRADIMED CORP: institutional ownership and insider trading
228 funds reported holding $804M of IRADIMED CORP in their latest 13F filings; in Q2 2026 funds net bought $19.4M, with 16 new positions and 27 funds selling out; over the last 12 months insiders bought $0 and sold $19.2M on the open market; over its last four quarters it reported revenue of $86.3M and net income of $23.1M.
IRMD revenue and earnings
- Quarter ended Jun 30, 2026: revenue $20.5M, net income $5.22M, EPS 0.41
- Quarter ended Mar 31, 2026: revenue $22.0M, net income $5.82M, EPS 0.45
- Quarter ended Dec 31, 2025: revenue $22.7M, net income $6.44M, EPS 0.50
- Quarter ended Sep 30, 2025: revenue $21.2M, net income $5.58M, EPS 0.43
Famous investors holding IRMD
- Renaissance Technologies (Renaissance Technologies): $37.7M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $17.5M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $927K, 0.0% of the portfolio
Largest institutional holders of IRMD
- BlackRock, Inc. (BLK) — $92.5M
- VANGUARD GROUP INC — $54.5M
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC — $37.9M
- RENAISSANCE TECHNOLOGIES LLC — $37.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $34.9M
- Copeland Capital Management, LLC — $32.9M
- T. Rowe Price Investment Management, Inc. — $30.5M
- GEODE CAPITAL MANAGEMENT, LLC — $27.7M
- Nine Ten Capital Management LLC — $24.5M
- DIMENSIONAL FUND ADVISORS LP — $21.9M
Recent IRMD insider trades
- Sep 3, 2026: Allen Monty K sold 1,419 shares ($123K)
- Jun 4, 2026: Scharen-Guivel Hilda Frederique sold 3,000 shares ($285K)
- Jun 1, 2026: Susi Roger E. sold 2,500 shares ($227K)
- May 27, 2026: Susi Roger E. sold 7,500 shares ($691K)
5%+ owners
- BlackRock, Inc.: 5.0% (Schedule 13G, filed Jul 28, 2026)